Improving institutional fairness to live kidney donors: Donor needs must be addressed by safeguarding donation risks and compensating donation costs

Transplant International

Volumn 20, Issue 11, 2007, Pages 940-946

  Schulz Baldes, Annette ^b   Delmonico, Francis L ^a  

^a Transplantation Society   (Canada)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Disincentives; Donor needs; Fairness; Healthcare institutions; Justice; Live kidney donation

Indexed keywords

ARTICLE; COMPENSATION; COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; HEALTH CARE; HEALTH CARE POLICY; HUMAN; KIDNEY DONOR; LIVING DONOR; NEPHRECTOMY; ORGAN DONOR; PRIORITY JOURNAL; RISK ASSESSMENT;

COMMERCE; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; TISSUE AND ORGAN PROCUREMENT; TRAVEL;

EID: 35148834691     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2007.00542.x     Document Type: Article

References (37)

1. World Health Organization. Global Knowledge Base on Transplantation (GKT) cited 2007 June 18]; Available from: http://www.who.int/transplantation/ knowledgebase/en/
2. Chkhotua AB, Klein T, Shabtai E, et al. Kidney transplantation from living-unrelated donors: comparison of outcome with living-related and cadaveric transplants under current immunosuppressive protocols. Urology 2003 62: 1002.
3. Delmonico F Council of the Transplantation Society. A report of the Amsterdam forum on the care of the live kidney donor: data and medical guidelines. Transplantation 2005 79 (Suppl. S53.
4. Moosa MR, Kidd M. The dangers of rationing dialysis treatment: the dilemma facing a developing country. Kidney Int 2006 70: 1107.
5. Goyal M, Mehta RL, Schneiderman LJ, Sehgal AR. Economic and health consequences of selling a kidney in India. JAMA 2002 288: 1589.
6. Zargooshi J. Quality of life of Iranian kidney "donors". J Urol 2001 166: 1790.
7. Prasad GV, Shukla A, Huang M, DAH RJ, Zaltzman JS. Outcomes of commercial renal transplantation: a Canadian experience. Transplantation 2006 82: 1130.
8. Colakoglu M, Yenicesu M, Akpolat T, et al. Nonrelated living-donor kidney transplantation: medical and ethical aspects. Nephron 1998 79: 447.
9. World Health Organization. Guiding Principles on Human Organ Transplantation. 1991 [cited 2007 June 18]; Available from: http://www.who.int/ ethics/topics/transplantation_guiding_principles/en/.
10. World Health Organization. WHA57.18 Human organ and tissue transplantation. 2004 [cited 2007 June 18]; Available from: http://www.who.int/ gb/ebwha/pdf_files/WHA57/A57_R18-en.pdf
11. World Health Organization Eastern Mediterranean Region. Kuwait Statement on Cell, Tissue and Organ Transplantation. Kuwait 27 November 2006.
12. World Health Organization Regional Office for the Western Pacific. Report. Consultation Meeting on Transplantation with National Health Authorities in the Western Pacific Region (Manila, Philippines, 7-9 November 2005). Manila: WHO, 2006.
13. World Medical Association. World Medical Association Statement on Human Organ Donation and Transplantation. 2000 [cited 2007 June 18]; Available from: http://www.wma.net/e/policy/wma.htm
14. Council of The Transplantation Society. Commercialization in transplantation: the problems and some guidelines for practice. Lancet 1985 2: 715.
15. Commission of the European Communities. Communication from the Commission to the European Parliament and the Council. Organ Donation and Transplantation: Policy Actions at EU Level. Brussels. 2007 [cited 2007 June 18]; Available from: http://www.ec.europa.eu/health/ph_threats/human_substance/oc_organs/ oc_organs_en.htm
16. Council of Europe. Recommendation Rec(2004)7 of the Committee of Ministers to member states on organ trafficking. 2004 [cited 2007 June 18]; Available from: https://wcd.coe.int/ViewDoc.jsp?id=744621&Lang=en
17. Watts J. China introduces new rules to deter human organ trade. Lancet 2007 369: 1917.
18. Institute of Medicine. Organ Donation: Opportunities for Action. Washington: National Academy of Sciences, 2006.
19. Daniels N. Just Health Care. Boston, MA: Cambridge University Press, 1985.
20. Ethics Committee of the Transplantation Society. The consensus statement of the Amsterdam Forum on the Care of the Live Kidney Donor. Transplantation 2004 78: 491.
21. Ommen ES, Winston JA, Murphy B. Medical risks in living kidney donors: absence of proof is not proof of absence. Clin J Am Soc Nephrol 2006 1: 885.
22. Ellison MD, McBride MA, Taranto SE, Delmonico FL, Kauffman HM. Living kidney donors in need of kidney transplants: a report from the organ procurement and transplantation network. Transplantation 2002 74: 1349.
23. U.S. Department of Health and Human Services. ASPE Issue Brief. Overview of the Uninsured in the United States: An Analysis of the 2005 Current Population Survey. Washington 2005 [cited 2007 June 18]; Available from: http://aspe.hhs.gov/health/reports/05/uninsured-cps/index.htm
24. Matas AJ, Bartlett ST, Leichtman AB, Delmonico FL. Morbidity and mortality after living kidney donation, 1999-2001: survey of United States transplant centers. Am J Transplant 2003 3: 830.
25. Council of Europe. Additional Protocol to the Convention on Human Rights and Biomedicine, on Transplantation of Organs and Tissues of Human Origin 2005 [cited 2007 June 18]; Available from: http://conventions.coe.int/Treaty/EN/ Treaties/Html/186.htm
26. Wolters HH, Heidenreich S, Senninger N. Living donor kidney transplantation: chance for the recipient-financial risk for the donor? Transplant Proc 2003 35: 2091.
27. Clarke KS, Klarenbach S, Vlaicu S, Yang RC, Garg AX. The direct and indirect economic costs incurred by living kidney donors-a systematic review. Nephrol Dial Transplant 2006 21: 1952.
28. Yang RC, Thiessen-Philbrook H, Klarenbach S, Vlaicu S, Garg AX. for the Donor Nephrectomy Outcomes Reserach (DONOR) Network. Insurability of living organ donors: a systematic review. Am J Transplant 2007 7: 1.
29. Biller-Andorno N. Gender imbalance in living organ donation. Med Health Care Philos 2002 5: 199.
30. Gaston RS, Danovitch GM, Epstein RA, Kahn JP, Matas AJ, Schnitzler MA. Limiting financial disincentives in live organ donation: a rational solution to the kidney shortage. Am J Transplant 2006 6: 2548.
31. Shaheen FA, Kurpad R, Al-Attar BA, Al-Khader AA. A proposed Saudi approach to the ethical utilization of living unrelated kidney donation. Transplant Proc 2005 37: 2004.
32. Frenk J, Gonzalez-Pier E, Gomez-Dantes O, Lezana MA, Knaul FM. Comprehensive reform to improve health system performance in Mexico. Lancet 2006 368: 1524.
33. Gonzalez-Pier E, Gutierrez-Delgado C, Stevens G, et al. Priority setting for health interventions in Mexico's System of Social Protection in Health. Lancet 2006 368: 1608.
34. Delmonico FL, Arnold R, Scheper-Hughes N, Siminoff LA, Kahn J, Youngner SJ. Ethical incentives-not payment-for organ donation. N Engl J Med 2002 346: 2002.
35. McCune TR, Armata T, Mendez-Picon G, et al. The Living Organ Donor Network: a model registry for living kidney donors. Clin Transplant 2004 18 (Suppl. 12 33.
36. Garcia VD, Garcia CD, Keitel E, et al. Expanding criteria for the use of living donors: what are the limits? Transplant Proc 2004 36: 808.
37. Israni AK, Halpern SD, Zink S, Sidhwani SA, Caplan A. Incentive models to increase living kidney donation: encouraging without coercing. Am J Transplant 2005 5: 15.